No black box warning on record for Blenrep

As of the latest FDA labeling reviewed, Blenrep (BELANTAMAB MAFODOTIN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Blenrep medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Thrombocytopenia: Monitor complete blood counts at baseline and periodically during treatment. Withhold or reduce the dosage based on severity. ( 2.3 , 5.3 ) • Embryo‑fetal Toxicity: Can cause fetal harm. Advise patients of the potential risk to fetus and to use effective contraception. ( 5.4 , 8.1 , 8.3 ) 5.1 Ocular Toxicity BLENREP causes ocular toxicity, defined as

No black box warning on record for Blenrep

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Thrombocytopenia: Monitor complete blood counts at baseline and periodically during treatment. Withhold or reduce the dosage based on severity. ( 2.3 , 5.3 ) • Embryo‑fetal Toxicity: Can cause fetal harm. Advise patients of the potential risk to fetus and to use effective contraception. ( 5.4 , 8.1 , 8.3 ) 5.1 Ocular Toxicity BLENREP causes ocular toxicity, defined as

Blenrep Black Box Warning

No black box warning on record for Blenrep

Other warnings & precautions

Blenrep Black Box Warning

No black box warning on record for Blenrep

Other warnings & precautions